140 related articles for article (PubMed ID: 19095951)
1. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
Lin Z; Yemelyanova AV; Gambhira R; Jagu S; Meyers C; Kirnbauer R; Ronnett BM; Gravitt PE; Roden RB
Am J Pathol; 2009 Jan; 174(1):136-43. PubMed ID: 19095951
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
Becker KA; Florin L; Sapp C; Maul GG; Sapp M
J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
[TBL] [Abstract][Full Text] [Related]
3. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
4. Distribution and location of Daxx in cervical epithelial cells with high risk human papillomavirus positive.
Tang SY; Li L; Li YL; Liu AY; Yu MJ; Wan YP
Diagn Pathol; 2014 Jan; 9():1. PubMed ID: 24398161
[TBL] [Abstract][Full Text] [Related]
5. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2.
Florin L; Schäfer F; Sotlar K; Streeck RE; Sapp M
Virology; 2002 Mar; 295(1):97-107. PubMed ID: 12033769
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Daxx and HPV16 E6 and its significance in cervical lesions].
Zhou L; Zhang H; Huang C; Pang X; Zhang S
Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(37):3050-3. PubMed ID: 26814089
[TBL] [Abstract][Full Text] [Related]
7. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
Day PM; Baker CC; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14252-7. PubMed ID: 15383670
[TBL] [Abstract][Full Text] [Related]
8. Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization.
Becker KA; Florin L; Sapp C; Sapp M
Virology; 2003 Sep; 314(1):161-7. PubMed ID: 14517069
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.
Wang JW; Jagu S; Wu WH; Viscidi RP; Macgregor-Das A; Fogel JM; Kwak K; Daayana S; Kitchener H; Stern PL; Gravitt PE; Trimble CL; Roden RB
Clin Vaccine Immunol; 2015 Jul; 22(7):806-16. PubMed ID: 25972404
[TBL] [Abstract][Full Text] [Related]
10. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.
Day PM; Roden RB; Lowy DR; Schiller JT
J Virol; 1998 Jan; 72(1):142-50. PubMed ID: 9420209
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of DAXX and human papillomavirus type 16 E2 protein].
Tang SY; Li L; Liu Y; Liu AY; Yu MJ; Zhang Y; Liu LZ; Wan YP
Mol Biol (Mosk); 2014; 48(4):682-6. PubMed ID: 25842852
[TBL] [Abstract][Full Text] [Related]
12. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
14. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
15. HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer.
Namvar A; Bolhassani A; Hashemi M
Bratisl Lek Listy; 2016; 117(3):179-84. PubMed ID: 26925750
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins.
Görnemann J; Hofmann TG; Will H; Müller M
Virology; 2002 Nov; 303(1):69-78. PubMed ID: 12482659
[TBL] [Abstract][Full Text] [Related]
17. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
18. A protective and broadly cross-neutralizing epitope of human papillomavirus L2.
Gambhira R; Karanam B; Jagu S; Roberts JN; Buck CB; Bossis I; Alphs H; Culp T; Christensen ND; Roden RB
J Virol; 2007 Dec; 81(24):13927-31. PubMed ID: 17928339
[TBL] [Abstract][Full Text] [Related]
19. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.
Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK
J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of tumor suppressor gene PML in uterine cervical carcinogenesis: impact of human papillomavirus infection (HPV).
Singh N; Sobti RC; Suri V; Nijhawan R; Sharma S; Das BC; Bharadwaj M; Hussain S
Gynecol Oncol; 2013 Mar; 128(3):420-6. PubMed ID: 23220564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
